Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 23, 2026
Anthera Pharmaceuticals Market Cap
Anthera Pharmaceuticals has a market cap or net worth of $2.62 thousand as of November 3, 2026. It is the 52,275th most valuable company in the world and the 8,224th biggest in the United States. Its market cap has decreased by 90.00% in one year.
Market Cap
2.62K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,224 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2010, Anthera Pharmaceuticals's market cap has decreased from 10.98M to 2.62K, a decrease of -99.98%. That is a compound annual growth rate of -39.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 3.53K | 34.99% |
| Dec 31, 2025 | 2.62K | 9,969.23% |
| Dec 31, 2024 | 26.00 | -98.52% |
| Dec 29, 2023 | 1.75K | -33.00% |
| Dec 30, 2022 | 2.62K | -99.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |
| Synovics Pharmaceuticals | 3.65K |
| Rebus Holdings | 3.21K |
| Innoveren Scientific | 3.20K |
| Hemagen Diagnostics | 3.10K |
| Comera Life Sciences Holdings | 3.07K |
| Lipella Pharmaceuticals | 2.77K |